.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fuji
Federal Trade Commission
Medtronic
McKesson
Deloitte
McKinsey
Argus Health
Covington
Accenture
Cerilliant

Generated: November 20, 2017

DrugPatentWatch Database Preview

Details for Patent: ► Subscribe

« Back to Dashboard

Details for Patent: ► Subscribe

Title: Film forming compositions comprising modified starches and iota-carrageenan and methods for manufacturing soft capsules using same
Abstract:Disclosed herein are compositions comprising a modified starch and a carrageenan, especially iota-carrageenan, where the compositions are suitable for use in manufacturing soft capsules.
Inventor(s): Tanner; Keith Edward (Safety Harbor, FL), Draper; Peter Robert (LaSalle, CA), Getz; John J. (Delray Beach, FL), Burnett; Stephen W. (Clearwater, FL), Youngblood; Elizabeth (Valrico, FL)
Assignee: R.P. Scherer Technologies, Inc. (Paradise Valley, NV)
Filing Date:Jun 30, 2000
Application Number:09/608,853
Claims:1. An edible, soft capsule which comprises a soft, dry shell which comprises:

(v) about 12-24 weight % iota-carrageenan;

(vi) about 30-60 weight % modified starch;

(vii) about 10-60 weight % plasticizer;

(viii) about 1-4 weight % sodium phosphate dibasic buffer system; and

wherein said shell encloses a soft capsule fill material.

2. A soft capsule according to claim 1 wherein the plasticizer is comprised of glycerin or sorbitol or a mixture thereof and the modified starch is selected from the group consisting of modified corn starch, acid modified hydroxypropylated corn starch and hydroxypropylated acid modified tapioca starch.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Deloitte
Novartis
Fish and Richardson
Queensland Health
Fuji
Daiichi Sankyo
QuintilesIMS
AstraZeneca
US Department of Justice
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot